Published in J Exp Med on May 01, 1976
In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity (2002) 14.57
Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science (2008) 7.87
Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. N Engl J Med (2008) 7.80
CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med (2000) 7.46
Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med (1997) 5.72
Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A (1999) 5.66
Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med (1998) 5.59
Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med (1999) 5.55
Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J Exp Med (1990) 5.35
Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med (1996) 5.21
Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med (1997) 4.01
Cross-presentation by dendritic cells. Nat Rev Immunol (2012) 3.95
Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med (1990) 3.73
Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med (1998) 3.58
Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci U S A (1993) 3.27
Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J Exp Med (2003) 3.21
The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med (2002) 2.93
The known unknowns of antigen processing and presentation. Nat Rev Immunol (2008) 2.85
Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat Immunol (2009) 2.80
Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J Exp Med (2002) 2.54
Cross-priming in health and disease. Nat Rev Immunol (2010) 2.51
Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo. J Exp Med (2002) 2.32
Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med (1996) 2.32
CD4 T cells and their role in antitumor immune responses. J Exp Med (1999) 2.27
Cancer immunotherapy--revisited. Nat Rev Drug Discov (2011) 2.26
Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med (1998) 2.24
Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med (1995) 2.24
Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med (1996) 2.18
RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8⁺ T cells. Science (2015) 2.09
Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc Natl Acad Sci U S A (1998) 2.05
Antigen presentation to cytotoxic T lymphocytes in vivo. J Exp Med (1995) 1.98
Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles. Immunology (2006) 1.92
Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Exp Med (1999) 1.88
The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci U S A (1993) 1.86
Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med (1998) 1.83
Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes. J Exp Med (1992) 1.82
Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol (2004) 1.82
Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. J Clin Invest (2004) 1.65
Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice. Infect Immun (1998) 1.64
CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens. J Exp Med (2004) 1.56
Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J Exp Med (2000) 1.54
Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus. Infect Immun (1980) 1.50
Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo. J Exp Med (2005) 1.50
CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules. J Exp Med (2002) 1.49
Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells. J Exp Med (2003) 1.49
CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes. J Exp Med (2000) 1.48
Uncoupling of proliferative potential and gain of effector function by CD8(+) T cells responding to self-antigens. J Exp Med (2002) 1.44
Fc gamma receptors and cross-presentation in dendritic cells. J Exp Med (2002) 1.43
Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens. J Exp Med (2000) 1.39
Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice. Proc Natl Acad Sci U S A (1994) 1.38
Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations. Proc Natl Acad Sci U S A (2002) 1.38
Drinking a lot is good for dendritic cells. Immunology (2006) 1.36
T-cell populations specifically depleted of alloreactive potential cannot be induced to lyse H-2-different virus-infected target cells. J Exp Med (1978) 1.36
Apoptotic cells deliver processed antigen to dendritic cells for cross-presentation. PLoS Biol (2005) 1.35
Peyer's patch dendritic cells process viral antigen from apoptotic epithelial cells in the intestine of reovirus-infected mice. J Exp Med (2004) 1.35
Natural endogenous adjuvants. Springer Semin Immunopathol (2004) 1.34
CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity. Proc Natl Acad Sci U S A (2002) 1.34
Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation. Blood (2008) 1.32
Haplotype-specific suppression of cytotoxic T cell induction by antigen inappropriately presented on T cells. J Exp Med (1983) 1.31
Defective cross-presentation of viral antigens in GILT-free mice. Science (2010) 1.30
Dendritic cells cross-present latency gene products from Epstein-Barr virus-transformed B cells and expand tumor-reactive CD8(+) killer T cells. J Exp Med (2001) 1.30
Antigen-pulsed CD8alpha+ dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node. J Exp Med (1999) 1.28
Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J Exp Med (1998) 1.28
Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells. Infect Immun (2007) 1.26
Tumor-derived autophagosome vaccine: induction of cross-protective immune responses against short-lived proteins through a p62-dependent mechanism. Clin Cancer Res (2011) 1.24
Interactions of viruses with dendritic cells: a double-edged sword. J Exp Med (1997) 1.20
On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity. J Exp Med (2002) 1.20
T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice. J Exp Med (1999) 1.18
Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells. Proc Natl Acad Sci U S A (2011) 1.18
TAP-1 indirectly regulates CD4+ T cell priming in Toxoplasma gondii infection by controlling NK cell IFN-gamma production. J Exp Med (2007) 1.17
Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J Exp Med (2004) 1.15
Major histocompatibility complex class II presentation of cell-associated antigen is mediated by CD8alpha+ dendritic cells in vivo. J Exp Med (2002) 1.15
Antigen processing and remodeling of the endosomal pathway: requirements for antigen cross-presentation. Front Immunol (2012) 1.15
The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model. J Virol (1996) 1.14
Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo? J Exp Med (1996) 1.13
H-2 restriction as a consequence of intentional priming: T cells of fully allogeneic chimeric mice as well as of normal mice respond to foreign antigens in the context of H-2 determinants not encountered on thymic epithelial cells. Proc Natl Acad Sci U S A (1980) 1.13
Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors. J Virol (2001) 1.11
Pathways for antigen cross presentation. Springer Semin Immunopathol (2004) 1.10
Regulatory function of in vivo anergized CD4(+) T cells. Proc Natl Acad Sci U S A (2001) 1.10
The endosome-lysosome pathway and information generation in the immune system. Biochim Biophys Acta (2011) 1.08
Lymphocytes genetically modified to express tumor antigens target DCs in vivo and induce antitumor immunity. J Clin Invest (2007) 1.06
Immunological ignorance of solid tumors. Springer Semin Immunopathol (2005) 1.05
Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells. Proc Natl Acad Sci U S A (1996) 1.04
Suppressor T cells activated in a primary in vitro response to non-major histocompatibility alloantigens. J Exp Med (1982) 1.04
Transcription factor networks in dendritic cell development. Semin Immunol (2011) 1.03
An ITAM-signaling pathway controls cross-presentation of particulate but not soluble antigens in dendritic cells. J Exp Med (2007) 1.02
Direct, help-independent priming of CD8+ T cells by adeno-associated virus-transduced hepatocytes. Hepatology (2010) 1.02
Cross-presentation: dendritic cells and macrophages bite off more than they can chew! Immunology (2004) 1.01
Cross-priming of cytotoxic T cells promoted by apoptosis-inducing tumor cell reactive antibodies? J Clin Immunol (2002) 1.01
MyD88 expression is required for efficient cross-presentation of viral antigens from infected cells. J Virol (2005) 1.00
Expression of angiotensin-converting enzyme changes major histocompatibility complex class I peptide presentation by modifying C termini of peptide precursors. J Biol Chem (2008) 0.99
Cross-priming for antitumor CTL induced by soluble Ag + polyI:C depends on the TICAM-1 pathway in mouse CD11c(+)/CD8α(+) dendritic cells. Oncoimmunology (2012) 0.98
The cystine/glutamate antiporter regulates dendritic cell differentiation and antigen presentation. J Immunol (2010) 0.97
Cross-priming utilizes antigen not available to the direct presentation pathway. Immunology (2006) 0.97
Tumor antigen cross-presentation and the dendritic cell: where it all begins? Clin Dev Immunol (2010) 0.97
Primary CD8+ T-cell response to soluble ovalbumin is improved by chloroquine treatment in vivo. Clin Vaccine Immunol (2008) 0.97
The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells. Immunology (2006) 0.96
The function and interrelationships of T-cell receptors, Ir genes and other histocompatibility gene products. Transplant Rev (1975) 5.88
The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens. J Exp Med (1975) 5.83
In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice. J Exp Med (1975) 5.53
Genes required for cytotoxicity against virus-infected target cells in K and D regions of H-2 complex. Nature (1975) 4.41
Interaction antigens detected by cytotoxic T cells with the major histocompatibility complex as modifier. Nature (1975) 4.27
Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells. Eur J Immunol (1975) 3.37
Genetics and immunology of sex-linked antigens. Adv Immunol (1972) 2.71
A new method of typing inbred strains of mice for histocompatibility antigens. Transplant Bull (1957) 1.42
Absence of gene interaction in mouse hybrids, revealed by studies of immunological tolerance and homotransplantation. Proc Soc Exp Biol Med (1960) 1.39
T cell receptor antagonist peptides induce positive selection. Cell (1994) 18.66
Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell (1988) 8.01
Characterization of a murine monoclonal antibody specific for an allotypic determinant on T cell antigen receptor. J Immunol (1985) 7.90
Properties and applications of monoclonal antibodies directed against determinants of they Thy-1 locus. J Immunol (1979) 7.79
CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med (2000) 7.46
Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity (1998) 6.29
The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens. J Exp Med (1975) 5.83
Selecting and maintaining a diverse T-cell repertoire. Nature (1999) 5.35
Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med (2000) 5.07
In a radiation chimaera, host H-2 antigens determine immune responsiveness of donor cytotoxic cells. Nature (1977) 4.76
Low-affinity ligands for the TCR drive proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity (1999) 4.61
Interaction antigens detected by cytotoxic T cells with the major histocompatibility complex as modifier. Nature (1975) 4.27
H-2 antigens of the thymus determine lymphocyte specificity. J Exp Med (1978) 3.91
Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature (1991) 3.80
Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med (1990) 3.73
Positive selection of thymocytes. Annu Rev Immunol (1995) 3.68
Specific immunity to Listeria monocytogenes in the absence of IFN gamma. Immunity (1995) 3.54
Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? Cell Immunol (1977) 3.13
Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides. J Exp Med (1988) 2.82
Correlating notch signaling with thymocyte maturation. Immunity (1998) 2.82
Cytotoxic effects of antigen- and mitogen-induced T cells on various targets. J Immunol (1975) 2.80
Differences in the surface proteins of mouse B and T cells. Proc Natl Acad Sci U S A (1975) 2.78
Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J Exp Med (1989) 2.74
H-2M3 presents a Listeria monocytogenes peptide to cytotoxic T lymphocytes. Cell (1992) 2.70
CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J Exp Med (1992) 2.62
Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes. Immunity (2000) 2.58
Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J Exp Med (1993) 2.57
Expression and functional significance of the J11d marker on mouse thymocytes. J Immunol (1987) 2.56
Role of self-peptides in positively selecting the T-cell repertoire. Nature (1990) 2.47
Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis. J Immunol (1994) 2.41
Hybrid antibodies can target sites for attack by T cells. Nature (1985) 2.36
Killer cells reactive to altered-self antigens can also be alloreactive. Proc Natl Acad Sci U S A (1977) 2.35
The influence of thymus H-2 antigens on the specificity of maturing killer and helper cells. Immunol Rev (1978) 2.34
Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Nature (1992) 2.27
Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J Immunol (1993) 2.25
Defective presentation of endogenous antigen by a cell line expressing class I molecules. Science (1990) 2.25
RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity (1998) 2.15
Antigen recognition. Class discrimination in the world of immunology. Nature (1987) 2.10
Specificity of cytotoxic T cells from athymic mice. J Exp Med (1980) 2.07
N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells. J Virol (1986) 2.01
Differentiation potential of subsets of CD4-8- thymocytes. Nature (1987) 2.00
Minor H antigens introduced on H-2 different stimulating cells cross-react at the cytotoxic T cell level during in vivo priming. J Immunol (1976) 1.95
H-2 antigen-specific cytotoxic T cells induced by concanavalin A: estimation of their relative frequency. Eur J Immunol (1976) 1.95
Fractionation of lymphocyte populations with monoclonal antibodies specific for LYT-2.2 and LYT-3.1. J Immunol (1980) 1.86
Positive and negative selection invoke distinct signaling pathways. J Exp Med (1996) 1.86
Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides. J Immunol (1994) 1.85
T cell receptor antagonists and partial agonists. Immunity (1995) 1.83
Antigen recognition by cloned cytotoxic T lymphocytes follows rules predicted by the altered-self hypothesis. J Exp Med (1982) 1.80
Rearrangement and transcription of a T-cell receptor beta-chain gene in different T-cell subsets. Proc Natl Acad Sci U S A (1985) 1.78
Positive selection of CD8+ T cells induced by major histocompatibility complex binding peptides in fetal thymic organ culture. J Exp Med (1993) 1.77
Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen. J Exp Med (1982) 1.76
Specificity and flexibility in thymic selection. Nature (1994) 1.72
Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3. Immunity (1996) 1.70
Coordinate production by a T cell hybridoma of gamma interferon and three other lymphokine activities: multiple activities of a single lymphokine? J Immunol (1983) 1.67
Thymic cytotoxic T lymphocytes are primed in vivo to minor histocompatibility antigens. J Exp Med (1984) 1.63
CD8 T cells can protect against an intracellular bacterium in an interferon gamma-independent fashion. Proc Natl Acad Sci U S A (1992) 1.61
A differentiation factor required for the expression of cytotoxic T-cell function. Nature (1982) 1.56
Veto cells. Annu Rev Immunol (1988) 1.56
Evidence from in vitro studies that tolerance to self antigens is MHC-restricted. Nature (1984) 1.54
The Nrarp gene encodes an ankyrin-repeat protein that is transcriptionally regulated by the notch signaling pathway. Dev Biol (2001) 1.54
Positive selection of thymocytes. Adv Immunol (1995) 1.53
Antigen presentation to CD8+ T cells: cross-priming in infectious diseases. Curr Opin Immunol (2001) 1.53
The effect of 2-mercaptoethanol on murine mixed lymphocyte cultures. J Exp Med (1974) 1.52
Functional modifications of cytotoxic T-lymphocyte T200 glycoprotein recognized by monoclonal antibodies. Nature (1985) 1.51
Specificity of T-cell cones illustrates altered self hypothesis. Nature (1981) 1.50
Class I-restricted presentation occurs without internalization or processing of exogenous antigenic peptides. J Immunol (1989) 1.49
Transient expression of IL-2 receptor precedes the differentiation of immature thymocytes. Nature (1987) 1.48
Strong agonist ligands for the T cell receptor do not mediate positive selection of functional CD8+ T cells. Immunity (1995) 1.47
The CD8 response on autopilot. Nat Immunol (2001) 1.45
T-cell selection. Curr Opin Immunol (1998) 1.42
Dissection of major histocompatibility complex (MHC) and T cell receptor contact residues in a Kb-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs. Eur J Immunol (1992) 1.42
Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity. Proc Natl Acad Sci U S A (1986) 1.40
Self H-2 antigens influence the specificity of alloreactive cells. J Exp Med (1980) 1.40
Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens. J Exp Med (2000) 1.39
Induction of H-2-restricted cytotoxic T cells: in vivo induction has the appearance of being unrestricted. Cell Immunol (1977) 1.39
Different classes of T lymphocytes have different mRNAs for the leukocyte-common antigen, T200. J Exp Med (1986) 1.39
Identification of a natural T cell epitope presented by Salmonella-infected macrophages and recognized by T cells from orally immunized mice. J Immunol (1997) 1.38
Selective activation of Lyt 2+ precursor T cells by ligation of the antigen receptor. Nature (1985) 1.38
Cells infected with Yersinia present an epitope to class I MHC-restricted CTL. J Immunol (1994) 1.38
Cooperation between helper T cells and cytotoxic T lymphocyte precursors. Ann N Y Acad Sci (1988) 1.38
Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells. J Immunol (1987) 1.35
Increased peptide promiscuity provides a rationale for the lack of N regions in the neonatal T cell repertoire. Immunity (1995) 1.34
Notch signaling in T cell development. Curr Opin Immunol (2000) 1.32
Haplotype-specific suppression of cytotoxic T cell induction by antigen inappropriately presented on T cells. J Exp Med (1983) 1.31
Antigen-specific and nonspecific deletion of immature cortical thymocytes caused by antigen injection. Eur J Immunol (1997) 1.31
Thymocytes expressing CD8 differentiate into CD4+ cells following intrathymic injection. Proc Natl Acad Sci U S A (1988) 1.31
Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J Immunol (1997) 1.30
Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection. Infect Immun (1998) 1.26
Secretion of immune interferon and generation of cytotoxic T cell activity in nude mice are dependent on interleukin 2: age-associated endogenous production of interleukin 2 in nude mice. J Immunol (1983) 1.24
Monoclonal antibodies specific for a murine cytotoxic T-lymphocyte clone. Proc Natl Acad Sci U S A (1984) 1.24
An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S. J Exp Med (1992) 1.24
Mouse T-cell surface glycoprotein recognised by heterologous anti-thymocyte sera and its relationship to Thy-1 antigen. Nature (1975) 1.23
Cytotoxic t-cell response to histocompatibility antigens: the role of H-2. Cold Spring Harb Symp Quant Biol (1977) 1.21
Murine cytotoxic T lymphocytes induced following Chlamydia trachomatis intraperitoneal or genital tract infection respond to cells infected with multiple serovars. Infect Immun (1995) 1.20
Alloimmune cytotoxic T cells: Evidence that they recognize serologically defined antigens and bear clonally restricted receptors. J Immunol (1975) 1.20
Primary and secondary immune responses to Listeria monocytogenes. Curr Opin Immunol (1996) 1.19
A reexamination of the role of LYT-2-positive T cells in murine skin graft rejection. J Exp Med (1984) 1.17
Acquisition of cytotoxic T lymphocyte-specific carbohydrate differentiation antigens. J Exp Med (1985) 1.16
H2-M3 restricted presentation of a Listeria-derived leader peptide. J Exp Med (1998) 1.16